Despite 30 years of research and a bigger pipeline than ever, only a small number of gene therapy trials have completed late-stage testing or are currently in late-stage trials. Today, hundreds of clinical trials testing gene therapies are ongoing or recruiting, but the majority of such gene therapies are in phase I trials and probably won’t reach patients for many years.  (MIT Technology Review)